Controlled release of antibiotics from biomedical polyurethanes: morphological and structural features.
Polymer-associated infections are of increasing importance. Antistaphylococcal antimicrobial substances (ciprofloxacin, gentamycin, fosfomycin, flucloxacillin) were incorporated into polyurethanes by the solvent casting technique. Drug release rates, bacterial colonization and morphological features were evaluated to predict and understand the antimicrobial activity of these delivery systems. Drug release characteristics were investigated by standard bioassay and high-performance liquid chromatography (HPLC), and the physico-chemical mechanisms of the delivery were discussed. Ciprofloxacin hydrochloride showed a fast initial release rate, whereas gentamicin-base was characterized by a more continuous release type of behaviour. Bacterial colonization to the antibiotic-loaded polyurethanes was inhibited effectively by preparations showing a slower but more sustained antimicrobial delivery. Polyurethane-antibiotic combinations were most homogeneous for gentamicin-base and flucloxacillin as shown by scanning electron microscopy (SEM). In polymers loaded with fosfomycin and ciprofloxacin a granular structure of the crystallized drug embedded in the polyurethane matrix could be demonstrated. Physico-chemical similarity of the polymeric material and the antibiotics is important for the homogeneity of polymer-antibiotic combinations. High homogeneity is required for a sustained and prolonged release over time and effective inhibition of bacterial colonization.
Schierholz
J M
JM
Institute of Medical Microbiology and Hygiene, University of Cologne, Germany.
Steinhauser
H
H
Rump
A F
AF
Berkels
R
R
Pulverer
G
G
D000900:Anti-Bacterial Agents / Q000008:administration & dosage*; D001422:Bacterial Adhesion; D001672:Biocompatible Materials; D018441:Biofilms / Q000187:drug effects; D002939:Ciprofloxacin / Q000008:administration & dosage; D004343:Drug Implants; D005436:Floxacillin / Q000008:administration & dosage; D005578:Fosfomycin / Q000008:administration & dosage; D005839:Gentamicins / Q000008:administration & dosage; D006801:Humans; D008422:Materials Testing; D008855:Microscopy, Electron, Scanning; D011140:Polyurethanes; D019736:Prostheses and Implants / Q000009:adverse effects*; D016459:Prosthesis-Related Infections / Q000209:etiology / Q000517:prevention & control; D013203:Staphylococcal Infections / Q000209:etiology / Q000517:prevention & control
D000900:Anti-Bacterial Agents; D001672:Biocompatible Materials; D004343:Drug Implants; D005839:Gentamicins; D011140:Polyurethanes; D005578:Fosfomycin; D005436:Floxacillin; D002939:Ciprofloxacin